The Lambda Select cII Mutation Detection System

Journal of Visualized Experiments : JoVE
Ahmad Besaratinia, Stella Tommasi

Abstract

A number of transgenic animal models and mutation detection systems have been developed for mutagenicity testing of carcinogens in mammalian cells. Of these, transgenic mice and the Lambda (λ) Select cII Mutation Detection System have been employed for mutagenicity experiments by many research groups worldwide. Here, we describe a detailed protocol for the Lambda Select cII mutation assay, which can be applied to cultured cells of transgenic mice/rats or the corresponding animals treated with a chemical/physical agent of interest. The protocol consists of the following steps: (1) isolation of genomic DNA from the cells or organs/tissues of transgenic animals treated in vitro or in vivo, respectively, with a test compound; (2) recovery of the lambda shuttle vector carrying a mutational reporter gene (i.e., cII transgene) from the genomic DNA; (3) packaging of the rescued vectors into infectious bacteriophages; (4) infecting a host bacteria and culturing under selective conditions to allow propagation of the induced cII mutations; and (5) scoring the cII-mutants and DNA sequence analysis to determine the cII mutant frequency and mutation spectrum, respectively.

Citations

Jan 31, 2020·Epigenetics : Official Journal of the DNA Methylation Society·Andrew W CaliriAhmad Besaratinia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Related Papers

International Journal of Molecular Sciences
Ahmad BesaratiniaStella Tommasi
Proceedings of the National Academy of Sciences of the United States of America
R N WinnS Muller
Proceedings of the National Academy of Sciences of the United States of America
J A GossenJ Vijg
© 2022 Meta ULC. All rights reserved